AbCellera Biologics stock price
앱셀레라 바이오로직스NASDAQ:ABCL · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →AbCellera Biologics last closed at $13.74 (-1.22%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -25.5×. Its overall grade ranks 113 of 739 stocks in Healthcare.
About this company
AbCellera Biologics last closed at $13.74 (-1.22%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 113/739
Valuation grade A-
Related stocks
- Eli LillyCustomer
항체 신약 공동연구 및 파트너십의 대표 고객
- AbbVieCustomer
항체 발굴·개발 협력 이력이 있는 주요 제약 고객
- Novo NordiskCustomer
바이오의약품/항체 협력 가능성이 큰 대형 제약 고객
ETFs holding this stock
Virtus LifeSci Biotech Clinical Trials ETF
Details →About AbCellera Biologics
- What technical signals does AbCellera Biologics (ABCL) have?
- AbCellera Biologics current technical signals: no active technical signal.
- Is AbCellera Biologics a cup-and-handle pattern?
- No. AbCellera Biologics has no valid Cup signal right now.
- What published figures are available for AbCellera Biologics?
- Market cap: $4.11B. Trailing 12 months PER: -25.5×. Latest quarter PBR: 4.69×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about AbCellera Biologics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.